October Webinar: LSD Microdosing for Mood & Mental Health

Explore the cutting-edge research on LSD microdosing for mood and mental health in this webinar featuring leading researchers from the University of Auckland. This session highlights the world’s first government-sanctioned clinical trials, offering a real-world look at how microdosing can support emotional resilience, cognitive flexibility, and overall mental wellbeing.

Inside This Conversation

Pioneering Research and Unique Trial Design
Learn about the innovative New Zealand trials, where participants could microdose in their own homes rather than clinical labs—bringing ecological validity to groundbreaking science.

‍

The Nuance of Dosing and Perception
Discover how flexible dosing and personalized calibration, rather than strictly sub-perceptual protocols, can optimize benefits without disrupting daily life.

‍

Safety Profiles and Long-Term Considerations
Address common concerns—including cardiac safety and dependence—with evidence suggesting microdosing may have a safety profile superior to many conventional antidepressants.

‍

A New Frontier in Women’s Health
Explore how psychedelics like LSD could offer novel support for women during hormonal transitions and conditions like Premenstrual Dysphoric Disorder (PMDD), filling gaps left by traditional research.

‍

Expanding Benefits Beyond Symptom Relief
Understand how microdosing can foster pro-social connection, emotional resilience, and a deeper capacity for self-acceptance—even when physical symptoms remain.